Jim Simons acquired 601 Thousand Veracyte shares worth $18.7 Million. That's 0.03% of their equity portfolio (640th largest holding). The first Veracyte trade was made in Q4 2015. Since then Jim Simons bought shares fifteen more times and sold shares on eleven occasions. The stake costed the investor $15.3 Million, netting the investor a gain of 22% so far.